1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United States >
  6. Maryland >
  7. Supernus Pharmaceuticals >
  8. M&A

Supernus Pharmaceuticals Mergers & Acquisitions

Supernus Pharmaceuticals M&A Summary

Supernus Pharmaceuticals has acquired 4 companies, including 3 in the last 5 years.

Supernus Pharmaceuticals’ largest acquisition to date was in 2025, when it acquired Sage Therapeutics for $795M. Supernus Pharmaceuticals has acquired in 4 different US states. The Company’s most targeted sectors include life science (75%) and leisure (25%).

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity4
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Supernus Pharmaceuticals

Supernus Pharmaceuticals, Inc.

9715 Key West Avenue,
Rockville, Maryland 20850
United States,
(301) 838-2500
www.supernus.com

All (4) Buy (4) Sell (-)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-06-16 Sage Therapeutics · Leisure
Cambridge, Massachusetts · www.sagerx.com

Sage Therapeutics is a biopharmaceutical company that delivers brain health medicines. Sage developed the only two FDA-approved treatments indicated for postpartum depression and is advancing a pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Revenue (mlns) 41 USD
Advisors: Goldman Sachs , Kirkland & Ellis 		795
19.4x REVENUE 		Add-on Acquisition

Supernus Pharmaceuticals
Advisors: Moelis & Co. , Saul Ewing

-

Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal